// App-Quantinova.ai

1359 : Characterising Natural Killer cells in early Parkinson’s disease

Researchers

Presenter

  • J. Holbrook

Principal Investigators

  • B. Patel

  • M. Camacho

  • C. Williams-Gray

Medical Centers

  • N/A

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Parkinson's disease

Biomarkers

  • Natural Killer cells

  • Peripheral blood mononuclear cell

  • Cluster of Differentiation 2AP

  • Cluster of Differentiation 56

  • Fc gamma RIIIa

  • Natural killer group 2D

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved